Blood, nasal and airway immune responses to SARS-COV-2 vaccination in COPD patients and healthy subjects

T. Southworth (Manchester (Greater Manchester), United Kingdom), N. Jackson (Manchester (Greater Manchester), United Kingdom), D. Singh (Manchester (Greater Manchester), United Kingdom)

Source: International Congress 2022 – COPD clinical studies and exacerbations

Session: COPD clinical studies and exacerbations
Session type: Thematic Poster
Number: 3617

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Southworth (Manchester (Greater Manchester), United Kingdom), N. Jackson (Manchester (Greater Manchester), United Kingdom), D. Singh (Manchester (Greater Manchester), United Kingdom). Blood, nasal and airway immune responses to SARS-COV-2 vaccination in COPD patients and healthy subjects. 3617

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.